Pre-Open Stock Movers 12/16: (NVGN) (TLM) (BA) Higher; (CYCC) (FRO) (YNDX) Lower (more...) - InvestingChannel

Pre-Open Stock Movers 12/16: (NVGN) (TLM) (BA) Higher; (CYCC) (FRO) (YNDX) Lower (more…)

Novogen Limited (NASDAQ: NVGN) 104.6% HIGHER; announces that it has confirmed that its lead candidate product, TRXE-009, originally developed for the treatment of brain cancers, has been shown in pre-clinical studies also to be highly active against melanoma.

Cyclacel Pharma (NASDAQ: CYCC) 65.7% LOWER; announced enrollment of 486 patients, continuation to final analysis and recommendations of the independent Data and Safety Monitoring Board (DSMB) of the Company’s Phase 3 SEAMLESS study of oral sapacitabine capsules in acute myeloid leukemia (AML). All patients will continue to be followed up until mature data